DEVICE CATEGORY · NPS
Tricuspid Valve Repair Device, Percutaneously Delivered
These devices are intended to repair heart valves by methods other than that used by the classified device (annuloplasty rings). They may be placed using non-traditional techniques or other novel methods for decreasing valvular regurgitation.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 20, 2026 | FDA | |
TriClip SystemsP230007/S023 | ABBOTT MEDICAL | PMA supplement | Jun 25, 2026 | FDA |
TriClip Delivery SystemP230007/S022 | ABBOTT MEDICAL | PMA supplement | May 28, 2026 | FDA |
TriClip SystemsP230007/S021 | ABBOTT MEDICAL | PMA supplement | May 14, 2026 | FDA |
TriClip G4 SystemP230007/S020 | ABBOTT MEDICAL | PMA supplement | Mar 6, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 25, 2026 | FDA | |
TriClip G4 SystemP230007/S018 | ABBOTT MEDICAL | PMA supplement | Oct 17, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2025 | FDA | |
TriClip G5 Delivery SystemP230007/S015 | ABBOTT MEDICAL | PMA supplement | Aug 20, 2025 | FDA |
TriClip Delivery SystemP230007/S016 | ABBOTT MEDICAL | PMA supplement | Aug 18, 2025 | FDA |
Source information
Follow the FDA links to view the original records.






